Abstract
Preliminary results of a non-blinded prospective study of the effect of clozapine on symptomatology and social function in 51 treatment-resistant schizophrenic patients are reported. The mean duration of treatment at the time of this report was 10.3±8.1 months, median 7.6 months. Overall, 3/51 patients (60.8%) showed at least a 20% decrease in total BPRS, a criterion of improvement in the study of Kane et al. (1988). Four of 51 (7.8%) had at least a 50% decrease in total BPRS. Improvements in both positive and negative symptoms were noted. Marked improvements in social function were noted within the first 6 months of treatment. Improvement was first noted at all time points, with only 45.2% of improvers being identified after 6 weeks of treatment. These results suggest a 6–12-month trial may be desirable before deciding to discontinue clozapine because of insufficient response. Higher total Brief Psychiatric Rating Scale (BPRS) score and higher ratings on the Paranoid Disturbance subscales of the BPRS were factors which discriminated clozapine responders from non-responders.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Claghorn J, Honigfeld G, Abuzzahab FS, Wang R, Steinbook R, Tuason V, Klerman G (1987) The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 7:377–384
Endicott J, Spitzer RL (1978) A diagnostic interview: the Schedule for Affective Disorders and schizophrenia. Arch Gen Psychiatry 35:837–844
Heinrichs DW, Hanlon ET, Carpenter WT Jr (1984) The Quality of Life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophren Bull 10:388–396
Juul-Povlsen VJ, Noring V, Fog R, Gerlach J (1985) Tolerability and therapeutic effect of clozapine: a retrospective investigation of 216 patients treated with clozapine for up to 12 years. Acta Psychiatr Scand 71:176–185
Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison versus chlorpromazine/benztropine. Arch Gen Psychiatry 45:789–796
Krupp P (1989) Granulocytopenia associated with Leponex: A review of the situation. Psychopharmacology (in press)
Kuha S, Miettinen E (1986) Long-term effect of clozapine in schizophrenia: a retrospective study of 108 chronic schizophrenics treated with clozapine for up to 7 years. Nord Psychiatr Tidskr 40:225–230
Lehman AF (1983) The well-being of chronic mental patients: assessing their quality of life. Arch Gen Psychiatry 40:369–373
Lindström LH (1988) The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 77:524–529
Overall JE, Gorham DR (1962) Brief Psychiatric Rating Scale (BPRS). Psychol Rep 10:799–812
Wing JK, Cooper JE, Sartorius A (1974) The measurement and classification of psychiatric symptoms. Cambridge University Press, London
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meltzer, H.Y., Bastani, B., Kwon, K.Y. et al. A prospective study of clozapine in treatment-resistant schizophrenic patients. Psychopharmacology 99 (Suppl 1), S68–S72 (1989). https://doi.org/10.1007/BF00442563
Issue Date:
DOI: https://doi.org/10.1007/BF00442563